The present invention is directed to novel thia-tetraazaacenaphthylene compounds of Formula (I): and pharmaceutically acceptable forms thereof and their synthesis and use as inhibitors of ATP-protein kinase interactions.
-
Page/Page column 115
(2008/06/13)
More Articles about upstream products of 20131-39-9